Skip to main content
Clinical Trials/ACTRN12622000250730
ACTRN12622000250730Recruiting未知

Feasibility study of a novel resuscitation monitoring system for measuring mask leak and tidal volumes during neonatal resuscitation

ResusRight Pty Ltd0 sites30 target enrollmentStarted: February 11, 2022Last updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
Hours to o limit (—)
Sex
All

Inclusion Criteria

  • Neonatal participants: There are two groups of neonatal participants for this study.
  • Neonatal Group 1 - Resuscitation at birth
  • Neonates born from 30 weeks gestation that require manual positive pressure ventilation during resuscitation following birth will be recruited to the study.
  • Neonatal Group 2 - Neonatal Intensive Care Neonates
  • Neonates from 26 weeks gestation that are admitted to the NICU that require manual
  • positive pressure ventilation with a facemask during elective/semi-elective endotracheal
  • intubation during their NICU admission.
  • Clinician resuscitators: Medical officers will be eligible to participate if they fulfill all the following criteria:
  • i. Employed at the study site
  • ii. Neonatology Staff Specialist/Neonatal Fellow/neonatal registrar (with minimum 6 months NICU experience)
  • iii. Successfully attend resuscitation training with the NEMO resuscitation monitor.

Exclusion Criteria

  • Neonates will be excluded from the study if they meet the following exclusion criteria:
  • i.Born with a potentially lethal congenital abnormality.
  • ii.Acute, severe, fetal compromise indicating intrapartum still birth (e.g., cessation of fetal heart rate).
  • iii.Unavailability of independent senior resuscitator.
  • iv.Unavailability of research team.

Investigators

Sponsor
ResusRight Pty Ltd

Similar Trials